Skinvisible (SKVI) Change in Accured Expenses (2010 - 2026)

Skinvisible (SKVI) has 17 years of Change in Accured Expenses data on file, last reported at $101292.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 0.96% year-over-year to $101292.0; the trailing twelve-month figure through Mar 2026 stood at $395637.0 (down 7.22% YoY), and the FY2025 full-year result was $394676.0, down 6.1% from the prior year.
• Change in Accured Expenses climbed to $101292.0 in Q1 2026, from $97013.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $490421.0 in Q3 2024 to a low of -$291120.0 in Q4 2024.
• A 5-year average of $94816.1 and a median of $99852.0 in 2023 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses surged 1479.14% in 2022 and tumbled 363.82% in 2024, its largest moves.
• Tracing SKVI's Change in Accured Expenses over 5 years: stood at $91006.0 in 2022, then grew by 21.25% to $110349.0 in 2023, then plunged by 363.82% to -$291120.0 in 2024, then jumped by 133.32% to $97013.0 in 2025, then increased by 4.41% to $101292.0 in 2026.
• Business Quant data shows SKVI's Change in Accured Expenses at $101292.0 in Q1 2026, $97013.0 in Q4 2025, and $75504.0 in Q3 2025.